BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12773055)

  • 1. A short synthesis and biological evaluation of potent and nontoxic antimalarial bridged bicyclic beta-sulfonyl-endoperoxides.
    Bachi MD; Korshin EE; Hoos R; Szpilman AM; Ploypradith P; Xie S; Shapiro TA; Posner GH
    J Med Chem; 2003 Jun; 46(12):2516-33. PubMed ID: 12773055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro antimalarial activity of sulfone endoperoxides.
    Bachi MD; Korshin EE; Ploypradith P; Cumming JN; Xie S; Shapiro TA; Posner GH
    Bioorg Med Chem Lett; 1998 Apr; 8(8):903-8. PubMed ID: 9871509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial activity of yingzhaosu A analogues.
    Kim HS; Begum K; Ogura N; Wataya Y; Tokuyasu T; Masuyama A; Nojima M; McCullough KJ
    J Med Chem; 2002 Oct; 45(21):4732-6. PubMed ID: 12361400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally active antimalarial 3-substituted trioxanes: new synthetic methodology and biological evaluation.
    Posner GH; Cumming JN; Woo SH; Ploypradith P; Xie S; Shapiro TA
    J Med Chem; 1998 Mar; 41(6):940-51. PubMed ID: 9526568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial activity of the bicyclic peroxide Ro 42-1611 (arteflene) in experimental models.
    Jaquet C; Stohler HR; Chollet J; Peters W
    Trop Med Parasitol; 1994 Sep; 45(3):266-71. PubMed ID: 7899802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ro 42-1611 (arteflene), a new effective antimalarial: chemical structure and biological activity.
    Hofheinz W; Bürgin H; Gocke E; Jaquet C; Masciadri R; Schmid G; Stohler H; Urwyler H
    Trop Med Parasitol; 1994 Sep; 45(3):261-5. PubMed ID: 7899801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxides as oxidant antimalarials.
    Vennerstrom JL; Acton N; Lin AJ; Klayman DL
    Drug Des Deliv; 1989 Jan; 4(1):45-54. PubMed ID: 2673281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial activity of novel 1,2,5,6-tetraoxacycloalkanes and 1,2,5-trioxacycloalkanes.
    Kim HS; Begum K; Ogura N; Wataya Y; Nonami Y; Ito T; Masuyama A; Nojima M; McCullough KJ
    J Med Chem; 2003 May; 46(10):1957-61. PubMed ID: 12723958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting a basic chemosensitizing pharmacophore hypothesis. Part 1: synthesis and biological evaluation of novel arylbromide and bicyclic chemosensitizers against drug-resistant malaria parasites.
    Chouteau F; Ramanitrahasimbola D; Rasoanaivo P; Chibale K
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3024-8. PubMed ID: 15908208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and in vitro cancer cell growth inhibition evaluation and antimalarial testing of trioxanes installed in cyclic 2-enoate substructures.
    Hossain MI; Świtalska M; Peng W; Takashima M; Wang N; Kaiser M; Wietrzyk J; Dan S; Yamori T; Inokuchi T
    Eur J Med Chem; 2013 Nov; 69():294-309. PubMed ID: 24056020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antimalarial activity of cyclic peroxides, 1,2,4,5, 7-pentoxocanes and 1,2,4,5-tetroxanes.
    Kim HS; Shibata Y; Wataya Y; Tsuchiya K; Masuyama A; Nojima M
    J Med Chem; 1999 Jul; 42(14):2604-9. PubMed ID: 10411480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amine peroxides as potential antimalarials.
    Vennerstrom JL
    J Med Chem; 1989 Jan; 32(1):64-7. PubMed ID: 2642554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diels-Alder/thiol-olefin co-oxygenation approach to antimalarials incorporating the 2,3-dioxabicyclo[3.3.1]nonane pharmacophore.
    O'Neill PM; Verissimo E; Ward SA; Davies J; Korshin EE; Araujo N; Pugh MD; Cristiano ML; Stocks PA; Bachi MD
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2991-5. PubMed ID: 16527481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of chlorovinyl sulfones as structural analogs of chalcones and their antiplasmodial activities.
    Dominguez JN; Leon C; Rodrigues J; Gamboa de Dominguez N; Gut J; Rosenthal PJ
    Eur J Med Chem; 2009 Apr; 44(4):1457-62. PubMed ID: 19036479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro and in vivo antimalarial assessment of sulfide, sulfone and vinyl amide-substituted 1,2,4-trioxanes prepared via thiol-olefin co-oxygenation (TOCO) of allylic alcohols.
    Amewu R; Gibbons P; Mukhtar A; Stachulski AV; Ward SA; Hall C; Rimmer K; Davies J; Vivas L; Bacsa J; Mercer AE; Nixon G; Stocks PA; O'Neill PM
    Org Biomol Chem; 2010 May; 8(9):2068-77. PubMed ID: 20401383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.
    Biot C; Glorian G; Maciejewski LA; Brocard JS
    J Med Chem; 1997 Nov; 40(23):3715-8. PubMed ID: 9371235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial activity of 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol (N-251) and its carboxylic acid derivatives.
    Sato A; Kawai S; Hiramoto A; Morita M; Tanigawa N; Nakase Y; Komichi Y; Matsumoto M; Hiraoka O; Hiramoto K; Tokuhara H; Masuyama A; Nojima M; Higaki K; Hayatsu H; Wataya Y; Kim HS
    Parasitol Int; 2011 Dec; 60(4):488-92. PubMed ID: 21924377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total syntheses of Yingzhaosu A and of its C(14)-epimer including the first evaluation of their antimalarial and cytotoxic activities.
    Szpilman AM; Korshin EE; Rozenberg H; Bachi MD
    J Org Chem; 2005 Apr; 70(9):3618-32. PubMed ID: 15844999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of the antimalarial agent artemisinin. 7. Direct modification of (+)-artemisinin and in vivo antimalarial screening of new, potential preclinical antimalarial candidates.
    Avery MA; Alvim-Gaston M; Vroman JA; Wu B; Ager A; Peters W; Robinson BL; Charman W
    J Med Chem; 2002 Sep; 45(19):4321-35. PubMed ID: 12213073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.